Spero Therapeutics, Inc. Common Stock (SPRO) is a publicly traded Healthcare sector company. As of May 21, 2026, SPRO trades at $2.63 with a market cap of $149.39M and a P/E ratio of 0.00. SPRO moved +1.16% today. Year to date, SPRO is +8.23%; over the trailing twelve months it is +286.65%. Its 52-week range spans $0.51 to $3.22. Rallies surfaces SPRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SPRO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SPRO recently traded at $2.63. Market cap is $149.39M. P/E ratio is 0.00. Revenue is $13.51M.
| Metric | Value |
|---|---|
| Price | $2.63 |
| Market Cap | $149.39M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.22 |
| 52-Week Low | $0.51 |
| Volume | 1.08K |
| Avg Volume | 0 |
| Revenue (TTM) | $13.51M |
| Net Income | $-525.95K |
| Gross Margin | 57.80% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $66.80M | $8.57M | $0.15 |
| 2024 | $47.98M | $-68.57M | $-1.27 |
| 2023 | $103.78M | $22.81M | $0.43 |
| 2022 | $53.51M | $-46.41M | $-1.23 |
SPRO analyst coverage data. Average price target: $0.00.